2 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow Myoma: new trials by email Literature Review of Myoma trials Research Report on Myoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions Saline, Cross-linked Hyaluronan Hydrogel - Myomas, Ovary Cysts | Phase 1 / Phase 2 | Completed | BioRegen Biomedical (Changzhou) Co., Ltd | 216 | 2011-06-01 | 2014-06-18 |
| The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases Treatment of predefined abnormality by hysteroscopic surgery, Ofloxacinum/Doxycycline - Minor Intra-uterine Abnormalities | Phase 2 | Terminated | UMC Utrecht | 700 | 2007-06-01 | 2015-06-04 |
| Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation Adhibit Adhesion Prevention Gel, Standard of Care Comparator - Myoma | Phase 1 / Phase 2 | Completed | Angiotech Pharmaceuticals | 76 | 2003-07-01 | 2007-11-22 |
Tissue Adhesions (3) · Endometritis (1) · Polyps (1)
Cicatrix (3) · Fibrosis (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Muscle Tissue (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Adnexal Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Pathological Conditions, Anatomical (1) · Pelvic Inflammatory Disease (1)
Doxycycline (1) · Ofloxacin (1) · Sodium Chloride (1)
Angiotech Pharmaceuticals (1) · BioRegen Biomedical (Changzhou) Co., Ltd (1) · UMC Utrecht (1)
Canada (1) · China (1) · Germany (1) · Netherlands (1) · Netherlands Antilles (1)
Frank JM Broekmans, Dr. (1) · Human M Fatemi, Dr. (1) · Jenneke C Kasius (1) · Paul Devroey, Prof. dr. (1) · Zhenyu Zhang, MD, PhD (1)